[
  {
    "date": "2023-12-30",
    "symbol": "ARCT",
    "period": "FY",
    "netincomeloss": -29725000,
    "trdarrindname": "Dr. Padmanabh Chivukula",
    "trdarrindtitle": "Chief Scientific Officer and Chief Operating Officer",
    "rule10b51arradoptedflag": "false",
    "nonrule10b51arradoptedflag": "false",
    "trdarradoptiondate": "December 14, 2023",
    "rule10b51arrtrmntdflag": "false",
    "nonrule10b51arrtrmntdflag": "false",
    "trdarrsecuritiesaggavailamt": 152000,
    "trdarrexpirationdate": "September 15, 2025",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2023-12-31",
    "documentfiscalyearfocus": 2023,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ARCT",
    "entityregistrantname": "ARCTURUS THERAPEUTICS HOLDINGS INC.",
    "entitycentralindexkey": 1768224,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "documentfinstmterrorcorrectionflag": "false",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38942",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "32-0595345",
    "entityaddressaddressline1": "10628 Science Center Drive",
    "entityaddressaddressline2": "Suite 250",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "900-2660",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "San Diego, California",
    "cashandcashequivalentsatcarryingvalue": 292005000,
    "restrictedcash": 55000000,
    "accountsreceivablenetcurrent": 32064000,
    "prepaidexpensesandotherreceivables": 7521000,
    "assetscurrent": 386590000,
    "propertyplantandequipmentnet": 12427000,
    "operatingleaserightofuseasset": 28500000,
    "restrictedcashnoncurrent": 1885000,
    "assets": 429402000,
    "accountspayablecurrent": 5279000,
    "accruedliabilitiescurrent": 31881000,
    "deferredrevenuecurrent": 44829000,
    "liabilitiescurrent": 81989000,
    "deferredrevenuenoncurrent": 42496000,
    "operatingleaseliabilitynoncurrent": 25907000,
    "otherliabilitiesnoncurrent": 497000,
    "liabilities": 150889000,
    "commonstockvalue": 27000,
    "additionalpaidincapital": 646352000,
    "retainedearningsaccumulateddeficit": -367866000,
    "stockholdersequity": 278513000,
    "liabilitiesandstockholdersequity": 429402000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 26828000,
    "commonstocksharesoutstanding": 26828000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 157748000,
    "researchanddevelopmentexpense": 192133000,
    "generalandadministrativeexpense": 52871000,
    "operatingexpenses": 245004000,
    "operatingincomeloss": -78205000,
    "foreigncurrencytransactiongainlossbeforetax": -229000,
    "othernonoperatingincomeexpense": 16591000,
    "gainslossesonextinguishmentofdebt": 33953000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": -27890000,
    "incometaxexpensebenefit": 1835000,
    "earningspersharebasic": -1.12,
    "earningspersharediluted": -1.12,
    "weightedaveragenumberofsharesoutstandingbasic": 26628000,
    "weightedaveragenumberofdilutedsharesoutstanding": 26628000,
    "comprehensiveincomenetoftax": -29725000,
    "sharesoutstanding": 26828000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 34649000,
    "stockissuedduringperiodvaluestockoptionsexercised": 2668000,
    "stockissuedduringperiodsharesstockoptionsexercised": 238000,
    "stockissuedduringperiodvalueunderequityplan": 609000,
    "stockissuedduringperiodsharesunderequityplan": 35000,
    "depreciationandamortization": 2957000,
    "sharebasedcompensation": 34649000,
    "foreigncurrencytransactiongainlossrealized": -90000,
    "othernoncashincomeexpense": -502000,
    "increasedecreaseinaccountsreceivable": 29300000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": -1165000,
    "increasedecreaseoperatingleaserightofuseasset": -4045000,
    "increasedecreaseinaccountspayable": -2238000,
    "increasedecreaseinaccruedliabilities": -588000,
    "increasedecreaseincontractwithcustomerliability": 38606000,
    "increasedecreaseinoperatingleaseliability": -4309000,
    "netcashprovidedbyusedinoperatingactivities": -18099000,
    "paymentstoacquirepropertyplantandequipment": 2901000,
    "netcashprovidedbyusedininvestingactivities": -2901000,
    "proceedsfromissuanceofdebt": 20000000,
    "proceedsfromstockoptionsexercised": 2668000,
    "proceedsfromstockplans": 609000,
    "repaymentsofdebt": 47364000,
    "netcashprovidedbyusedinfinancingactivities": -24087000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -45087000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 348890000,
    "interestpaidnet": 2127000,
    "capitalexpendituresincurredbutnotyetpaid": 68000,
    "upfrontpaymentreceived": 200000000,
    "additionalmilestonepaymentsreceived": 23800000,
    "numberofoperatingsegments": 1,
    "debtinstrumentcollateralamount": 55000000,
    "concentrationrisknumberofcustomer": 2,
    "concentrationriskpercentage1": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "restrictedcashcurrent": 55000000,
    "contractwithcustomerassetnet": 32064000,
    "contractwithcustomerassetadditions": 205746000,
    "contractwithcustomerassetdeductions": -176446000,
    "contractwithcustomerliability": 87325000,
    "contractwithcustomerliabilityadditions": 205405000,
    "contractwithcustomerliabilityrevenuerecognized": -166799000,
    "developmentmilestonesachieved": 154200000,
    "achieveddevelopmentmilestoneincludedaccountsreceivable": 23800000,
    "developmentmilestonesreceivedadvancepayment": 23600000,
    "milestonepayments": 17500000,
    "additionalpaymentsuponmeetingcertainclinicalmilestones": 1500000,
    "revenueremainingperformanceobligation": 2400000,
    "reservedupfrontpayment": 11800000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 2500000,
    "grantrevenueoutstanding": 54100000,
    "assetsfairvaluedisclosure": 256100000,
    "employeerelatedliabilitiescurrent": 5918000,
    "accruedcysticfibrosisfoundationliability": 7633000,
    "taxespayablecurrent": 641000,
    "operatingleaseliabilitycurrent": 4309000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2023#AccruedLiabilitiesCurrent",
    "clinicaltrialaccrualscurrent": 2333000,
    "vinbiocarecontractualliabilities": 2514000,
    "otheraccruedresearchanddevelopmentexpenses": 8533000,
    "propertyplantandequipmentgross": 16046000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 8740000,
    "interestexpenselongtermdebt": 500000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 800000,
    "commonstockcapitalsharesreservedforfutureissuance": 193642,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 78800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 35300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 4300000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.761,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0391,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 18.87,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 7971127,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2140206,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 553999,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 3700692,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 7971127,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 33.55,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 27.38,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 11.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 34.31,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 38.04,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 33.55,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P6Y7M6D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P7Y10M24D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 53295000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 31142000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 53295000,
    "allocatedsharebasedcompensationexpense": 14950000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -27890000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -27890000,
    "currentfederaltaxexpensebenefit": 1246000,
    "currentstateandlocaltaxexpensebenefit": 589000,
    "currentincometaxexpensebenefit": 1835000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.019,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.025,
    "effectiveincometaxratereconciliationnondeductibleexpenseofficerscompensation": -0.074,
    "effectiveincometaxratereconciliationresearchanddevelopmentcredits": 0.2,
    "effectiveincometaxratereconciliationuncertaintaxposition": -0.024,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": 0.002,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.365,
    "effectiveincometaxratereconciliationotheradjustments": -0.003,
    "effectiveincometaxratereconciliationotherpermanentdifferences": -0.007,
    "effectiveincometaxratecontinuingoperations": -0.067,
    "deferredtaxassetsoperatinglosscarryforwards": 19147000,
    "deferredtaxassetstaxcreditcarryforwards": 10723000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 943000,
    "deferredtaxassetsdeferredincome": 7014000,
    "deferredtaxassetsinventory": 15961000,
    "deferredtaxassetsequitymethodinvestments": 2202000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 41971000,
    "deferredtaxassetsrightofuseleaseliability": 7233000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 11618000,
    "deferredtaxassetsgross": 116812000,
    "deferredtaxliabilitiespropertyplantandequipmentandintangibleassets": 1184000,
    "deferredtaxliabilitiesrightofuseasset": 6822000,
    "deferredincometaxliabilities": 8006000,
    "deferredtaxassetsvaluationallowance": 108806000,
    "valuationallowancedeferredtaxassetchangeinamount": 10200000,
    "maximumpercentageoflikelihoodofuncertaintaxpositionrecognizedtobesustained": 0.5,
    "operatinglosscarryforwards": 27900000,
    "operatinglosscarryforwardsexpirationyear": 2039,
    "taxcreditcarryforwardamount": 6300000,
    "taxcreditcarryforwardexpirationyear": 2037,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipminimumpercentage": 0.5,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipperiod": "P3Y",
    "unrecognizedtaxbenefits": 3600000,
    "unrecognizedtaxbenefitsdecreasesincreasesresultingfrompriorperiodtaxpositions": 100000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 600000,
    "contraexpenseremainingamountincludedinaccruedexpenses": 7600000,
    "contraexpenseincludedinresearchanddevelopmentexpense": 1400000,
    "lesseeoperatingleaseoptiontoextend": "The lease may be extended for one five-year period at the then current market rate with annual escalations",
    "operatingleasecost": 5600000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5646000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 4019000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 3603000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 3711000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfour": 19572000,
    "lesseeoperatingleaseliabilitypaymentsdue": 36551000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 6335000,
    "operatingleaseliability": 30216000,
    "operatingleaseweightedaverageremainingleaseterm1": "P8Y2M12D",
    "operatingleaseweightedaveragediscountratepercent": 0.048
  },
  {
    "date": "2022-12-30",
    "symbol": "ARCT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2022",
    "documentfiscalyearfocus": 2022,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ARCT",
    "entityregistrantname": "ARCTURUS THERAPEUTICS HOLDINGS INC.",
    "entitycentralindexkey": 1768224,
    "currentfiscalyearenddate": "December 31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Non-accelerated filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "true",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38942",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "32-0595345",
    "entityaddressaddressline1": "10628 Science Center Drive",
    "entityaddressaddressline2": "Suite 250",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "900-2660",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "San Diego, California",
    "cashandcashequivalentsatcarryingvalue": 391883000,
    "accountsreceivablenetcurrent": 2764000,
    "prepaidexpensesandotherreceivables": 8686000,
    "assetscurrent": 403333000,
    "propertyplantandequipmentnet": 12415000,
    "operatingleaserightofuseasset": 32545000,
    "restrictedcashnoncurrent": 2094000,
    "assets": 450387000,
    "accountspayablecurrent": 7449000,
    "accruedliabilitiescurrent": 30232000,
    "longtermdebtcurrent": 60655000,
    "deferredrevenuecurrent": 28648000,
    "liabilitiescurrent": 126984000,
    "deferredrevenuenoncurrent": 20071000,
    "operatingleaseliabilitynoncurrent": 30216000,
    "otherliabilitiesnoncurrent": 2804000,
    "liabilities": 180075000,
    "commonstockvalue": 27000,
    "additionalpaidincapital": 608426000,
    "retainedearningsaccumulateddeficit": -338141000,
    "stockholdersequity": -338141000,
    "liabilitiesandstockholdersequity": 450387000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 26555000,
    "commonstocksharesoutstanding": 26555000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 244000,
    "researchanddevelopmentexpense": 147751000,
    "generalandadministrativeexpense": 46071000,
    "operatingexpenses": 193822000,
    "operatingincomeloss": 12177000,
    "incomelossfromequitymethodinvestments": -515000,
    "foreigncurrencytransactiongainlossbeforetax": -500000,
    "othernonoperatingincomeexpense": -420000,
    "incomelossfromcontinuingoperationsbeforeincometaxesextraordinaryitemsnoncontrollinginterest": 10644000,
    "incometaxexpensebenefit": 1295000,
    "netincomeloss": 9349000,
    "earningspersharebasic": 0.35,
    "earningspersharediluted": 0.35,
    "weightedaveragenumberofsharesoutstandingbasic": 26445000,
    "weightedaveragenumberofdilutedsharesoutstanding": 27093000,
    "comprehensiveincomenetoftax": 9349000,
    "sharesoutstanding": 26555000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 30611000,
    "stockissuedduringperiodvaluestockoptionsexercised": 1730000,
    "stockissuedduringperiodsharesstockoptionsexercised": 161266,
    "stockissuedduringperiodvalueunderequityplan": 411000,
    "stockissuedduringperiodsharesunderequityplan": 22000,
    "depreciationandamortization": 1527000,
    "sharebasedcompensation": 30611000,
    "foreigncurrencytransactiongainlossrealized": -375000,
    "othernoncashincomeexpense": -2173000,
    "increasedecreaseinaccountsreceivable": -603000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 3584000,
    "increasedecreaseoperatingleaserightofuseasset": -3264000,
    "increasedecreaseinaccountspayable": -3112000,
    "increasedecreaseinaccruedliabilities": 9443000,
    "increasedecreaseincontractwithcustomerliability": -14694000,
    "increasedecreaseinoperatingleaseliability": -4477000,
    "netcashprovidedbyusedinoperatingactivities": 31993000,
    "paymentstoacquirepropertyplantandequipment": 7726000,
    "netcashprovidedbyusedininvestingactivities": -7726000,
    "proceedsfromstockoptionsexercised": 1730000,
    "proceedsfromstockplans": 411000,
    "repaymentsofdebt": 5000000,
    "netcashprovidedbyusedinfinancingactivities": -2859000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 21408000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 393977000,
    "interestpaidnet": 813000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 30191000,
    "capitalexpendituresincurredbutnotyetpaid": 573000,
    "upfrontpaymentreceived": 200000000,
    "numberofoperatingsegments": 1,
    "concentrationrisknumberofcustomer": 5,
    "concentrationriskpercentage1": 0.99,
    "equitymethodinvestmentownershippercentage": 0.5,
    "investmentownedpercentofnetassets": 0.06,
    "equitymethodinvestmentaggregatecost": 9200000,
    "upfrontfeeandconsideration": 9200000,
    "percentageofequityinterestinjointventure": 0.49,
    "propertyplantandequipmentusefullife": "five years",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "adoption",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "ten-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "four-year",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "no",
    "contractwithcustomerassetnet": 2764000,
    "contractwithcustomerassetadditions": 203077000,
    "contractwithcustomerassetdeductions": -203680000,
    "contractwithcustomerliability": 500000,
    "contractwithcustomerliabilityadditions": 203077000,
    "contractwithcustomerliabilityrevenuerecognized": 200000,
    "upfrontconsiderationreceived": 6000000,
    "revenuerecognitionpotentialmilestonerevenuerecognized": 138000000,
    "royaltypaymenttermdescription": "Ultragenyx will pay royalties as a single-digit percentage of net sales on a product-by-product and country-by-country basis during the applicable royalty term.",
    "revenuepracticalexpedientremainingperformanceobligationdescription": "The Company recognizes the reimbursement of labor and expenses as costs are incurred and none of the development and commercialization milestones were included in the transaction price, as all milestone amounts were fully constrained.",
    "revenuerecognitionreservetargetexclusivityperiod": 4,
    "developmentandoptionagreementdate": "January 2018",
    "upfrontfeereceived": 5000000,
    "collaborationagreementcontractualterm": "seven-month",
    "numberofreservedvaccinedoses": 500000,
    "reservedupfrontpayment": 11800000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 2800000,
    "reversalofrevenue": 2200000,
    "grantrevenueoutstanding": 63000000,
    "employeerelatedliabilitiescurrent": 4038000,
    "taxespayablecurrent": 1295000,
    "operatingleaseliabilitycurrent": 3884000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2022#AccruedLiabilitiesCurrent",
    "clinicalaccrualscurrent": 4531000,
    "vinbiocarecontractualliabilities": 7468000,
    "otheraccruedresearchanddevelopmentexpenses": 9016000,
    "propertyplantandequipmentgross": 18198000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 5783000,
    "repaymentsoflongtermdebt": 5000000,
    "longtermdebt": 50400000,
    "interestexpenselongtermdebt": 900000,
    "debtinstrumentpaymentterms": "The Loan Agreement was amended such that Arcturus Therapeutics, Inc. made monthly payments of interest only until August 1, 2022.",
    "prepaymentfeepercentage": 0.02,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 3700000,
    "commonstockcapitalsharesreservedforfutureissuance": 93142,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 81800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 39200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 1600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": 6.05,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.821,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.029300000000000003,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 15.56,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 850237,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 34.78,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 22.26,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 10.72,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 49.34,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 36.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 34.78,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": 7.1,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": 8.2,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 10721000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 9741000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 10721000,
    "allocatedsharebasedcompensationexpense": 30611,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": 10644000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": 10644000,
    "currentfederaltaxexpensebenefit": 1121000,
    "currentstateandlocaltaxexpensebenefit": 174000,
    "currentincometaxexpensebenefit": 1295000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.07200000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.161,
    "effectiveincometaxratereconciliationnondeductibleexpenseofficerscompensation": 0.218,
    "effectiveincometaxratereconciliationresearchanddevelopmentcredits": -0.40299999999999997,
    "effectiveincometaxratereconciliationuncertaintaxposition": 0.09,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.126,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.094,
    "effectiveincometaxratereconciliationotheradjustments": -0.01,
    "effectiveincometaxratereconciliationotherpermanentdifferences": 0.004,
    "effectiveincometaxratecontinuingoperations": 0.122,
    "deferredtaxassetsoperatinglosscarryforwards": 47866000,
    "deferredtaxassetstaxcreditcarryforwards": 10460000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 1420000,
    "deferredtaxassetsdeferredincome": 611000,
    "deferredtaxassetsinventory": 9016000,
    "deferredtaxassetsequitymethodinvestments": 2212000,
    "deferredtaxassetscapitalizedresearchanddevelopment": 19938000,
    "deferredtaxassetsrightofuseleaseliability": 8200000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 7201000,
    "deferredtaxassetsgross": 106924000,
    "deferredtaxliabilitiespropertyplantandequipmentandintangibleassets": 475000,
    "deferredtaxliabilitiesrightofuseasset": 7826000,
    "deferredincometaxliabilities": 8301000,
    "deferredtaxassetsvaluationallowance": 98623000,
    "valuationallowancedeferredtaxassetchangeinamount": -1000000,
    "maximumpercentageoflikelihoodofuncertaintaxpositionrecognizedtobesustained": 0.5,
    "operatinglosscarryforwards": 600000,
    "operatinglosscarryforwardsexpirationyear": 2038,
    "taxcreditcarryforwardamount": 2300000,
    "taxcreditcarryforwardexpirationyear": 2040,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipminimumpercentage": 0.5,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipperiod": "three-year",
    "unrecognizedtaxbenefits": 2900000,
    "unrecognizedtaxbenefitsdecreasesincreasesresultingfrompriorperiodtaxpositions": -500000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1000000,
    "contraexpenseincludedinresearchanddevelopmentexpense": 5200000,
    "lesseeoperatingleaseoptiontoextend": "the Company will have the right to extend the term of the lease for an additional five-year period",
    "operatingleasecost": 4700000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 5482000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 5646000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 4019000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 3603000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfour": 23283000,
    "lesseeoperatingleaseliabilitypaymentsdue": 42033000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 7933000,
    "operatingleaseliability": 34100000,
    "operatingleaseweightedaverageremainingleaseterm1": 8.8,
    "operatingleaseweightedaveragediscountratepercent": 0.05
  },
  {
    "date": "2021-12-30",
    "symbol": "ARCT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "December 31, 2021",
    "documentfiscalyearfocus": 2021,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ARCT",
    "entityregistrantname": "ARCTURUS THERAPEUTICS HOLDINGS INC.",
    "entitycentralindexkey": 1768224,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large accelerated filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "The Nasdaq Stock Market LLC",
    "entityfilenumber": "001-38942",
    "entityincorporationstatecountrycode": "Delaware",
    "entitytaxidentificationnumber": "32-0595345",
    "entityaddressaddressline1": "10628 Science Center Drive",
    "entityaddressaddressline2": "Suite 250",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "California",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "900-2660",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "auditorfirmid": 42,
    "auditorname": "Ernst & Young, LLP",
    "auditorlocation": "San Diego, California",
    "cashandcashequivalentsatcarryingvalue": 370492000,
    "accountsreceivablenetcurrent": 3367000,
    "prepaidexpensesandotherreceivables": 5102000,
    "assetscurrent": 378961000,
    "propertyplantandequipmentnet": 5643000,
    "operatingleaserightofuseasset": 5618000,
    "equitymethodinvestments": 515000,
    "restrictedcashnoncurrent": 2077000,
    "assets": 392814000,
    "accountspayablecurrent": 10058000,
    "accruedliabilitiescurrent": 23523000,
    "longtermdebtcurrent": 22474000,
    "deferredrevenuecurrent": 43482000,
    "liabilitiescurrent": 99537000,
    "deferredrevenuenoncurrent": 19931000,
    "longtermdebtnoncurrent": 40633000,
    "operatingleaseliabilitynoncurrent": 4502000,
    "liabilities": 164603000,
    "commonstockvalue": 26000,
    "additionalpaidincapital": 575675000,
    "retainedearningsaccumulateddeficit": -347490000,
    "stockholdersequity": -347490000,
    "liabilitiesandstockholdersequity": 392814000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": "null",
    "commonstocksharesoutstanding": 26372000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 3700000,
    "researchanddevelopmentexpense": 173760000,
    "generalandadministrativeexpense": 41451000,
    "operatingexpenses": 215211000,
    "operatingincomeloss": -202852000,
    "incomelossfromequitymethodinvestments": 515000,
    "foreigncurrencytransactiongainlossbeforetax": 600000,
    "othernonoperatingincomeexpense": -1921000,
    "netincomeloss": -203674000,
    "earningspersharebasicanddiluted": -7.74,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 26317000,
    "comprehensiveincomenetoftax": -203674000,
    "sharesoutstanding": 26372000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 28915000,
    "stockissuedduringperiodvalueacquisitions": 5000000,
    "stockissuedduringperiodsharesacquisitions": 75000,
    "stockissuedduringperiodvaluestockoptionsexercised": 902000,
    "stockissuedduringperiodsharesstockoptionsexercised": 93165,
    "stockissuedduringperiodvalueunderequityplan": 515000,
    "stockissuedduringperiodsharesunderequityplan": 13000,
    "depreciationandamortization": 1193000,
    "sharebasedcompensation": 28915000,
    "researchanddevelopmentinprocess": 5000000,
    "gainlossfromequitymethodinvestment": 515000,
    "foreigncurrencytransactiongainlossrealized": 577000,
    "othernoncashincomeexpense": -3382000,
    "increasedecreaseinaccountsreceivable": 1242000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2333000,
    "increasedecreaseinaccountspayable": -769000,
    "increasedecreaseinaccruedliabilities": 2783000,
    "increasedecreaseincontractwithcustomerliability": 32794000,
    "netcashprovidedbyusedinoperatingactivities": -135043000,
    "paymentstoacquirepropertyplantandequipment": 3406000,
    "netcashprovidedbyusedininvestingactivities": -3406000,
    "proceedsfromissuanceoflongtermdebt": 46599000,
    "proceedsfromstockoptionsexercised": 902000,
    "proceedsfromstockplans": 515000,
    "netcashprovidedbyusedinfinancingactivities": 48016000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": -90433000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 372569000,
    "interestpaidnet": 684000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1828000,
    "acquisitionofresearchanddevelopmentinprocessthroughissuanceofcommonstock": 5000000,
    "capitalexpendituresincurredbutnotyetpaid": 53000,
    "upfrontpaymentreceived": 27900000,
    "debtinstrumentfaceamount": 46600000,
    "numberofoperatingsegments": 1,
    "concentrationrisknumberofcustomer": 4,
    "concentrationriskpercentage1": 0.99,
    "equitymethodinvestmentownershippercentage": 0.5,
    "investmentownedpercentofnetassets": 0.12,
    "equitymethodinvestmentaggregatecost": 9200000,
    "upfrontfeeandconsideration": 9200000,
    "percentageofequityinterestinjointventure": 0.49,
    "propertyplantandequipmentusefullife": "five years",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "January 1, 2021",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "changeinaccountingprincipleaccountingstandardsupdateimmaterialeffect": "true",
    "contractwithcustomerassetnet": 3367000,
    "contractwithcustomerassetadditionsforrevenuerecognized": 35152000,
    "contractwithcustomerassetdeductionsforcashcollections": -33910000,
    "contractwithcustomerliability": 1400000,
    "contractwithcustomerliabilityadditionsforadvancedbillings": 45152000,
    "contractwithcustomerliabilityrevenuerecognized": -12359000,
    "revenuerecognitionpotentialmilestonerevenuerecognized": 23000000,
    "optionexerciserevenuerangepertarget": 1500000,
    "royaltypaymenttermdescription": "CureVac will pay royalties as a percentage of net sales on a product-by-product and country-by-country basis during the applicable royalty term in the low single-digit range",
    "revenuepracticalexpedientremainingperformanceobligationdescription": "The Company recognizes the reimbursement of labor and expenses as costs are incurred and none of the development and commercialization milestones were included in the transaction price, as all milestone amounts were fully constrained.",
    "revenuerecognitionreservetargetexclusivityperiod": 4,
    "developmentandoptionagreementdate": "January 2018",
    "expirationofintialterm": "eight years",
    "optiontoextendinitialtermonanannualbasis": "three years",
    "upfrontfeereceived": 5000000,
    "collaborationagreementcontractualterm": 19,
    "numberofreservedvaccinedoses": 500000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": 12,
    "employeerelatedliabilitiescurrent": 3578000,
    "accruedcysticfibrosisfoundationliability": 2777000,
    "operatingleaseliabilitycurrent": 1537000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "http://fasb.org/us-gaap/2021-01-31#OtherLiabilitiesCurrent",
    "clinicalaccrualscurrent": 8675000,
    "otheraccruedresearchanddevelopmentexpenses": 6956000,
    "propertyplantandequipmentgross": 9899000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 4256000,
    "potentialprincipalrepaymentsofdebtinstrument": 20900000,
    "longtermdebt": "null",
    "interestexpenselongtermdebt": 2700000,
    "prepaymentfeepercentage": 0.02,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": "null",
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": "null",
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": "null",
    "commonstockcapitalsharesreservedforfutureissuance": 78840,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumdiscountedpurchaseprice": 0.85,
    "allocatedsharebasedcompensationexpense": 28915000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumdiscountedamount": 25000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 97500000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": 3,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 28400000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisesinperiodtotalintrinsicvalue": 3600000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.737,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0113,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 26.71,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 277540,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": "null",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 44.62,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 41.87,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 9.68,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 56.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 29.48,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 44.62,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y3M10D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y18D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 47111000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 31322000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 47111000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -203674000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -203674000,
    "maximumpercentageoflikelihoodofuncertaintaxpositionrecognizedtobesustained": 0.5,
    "unrecognizedtaxbenefits": 2400000,
    "operatinglosscarryforwards": 226800000,
    "operatinglosscarryforwardsexpirationyear": 2034,
    "federalnetoperatinglossesoffsetpercent": 0.8,
    "taxcreditcarryforwardamount": 3100000,
    "taxcreditcarryforwardexpirationyear": 2039,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipminimumpercentage": 0.5,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipperiod": "P3Y",
    "unrecognizedtaxbenefitsdecreasesincreasesresultingfrompriorperiodtaxpositions": -100000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 1000000,
    "deferredtaxassetsoperatinglosscarryforwards": 69761000,
    "deferredtaxassetstaxcreditcarryforwards": 11020000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 910000,
    "deferredtaxassetsdeferredincome": 5098000,
    "deferredtaxassetsinventory": 5850000,
    "deferredtaxassetsequitymethodinvestments": 1957000,
    "deferredtaxassetspropertyplantandequipmentandintangibleassets": 960000,
    "deferredtaxassetsleaseliability": 1360000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 3971000,
    "deferredtaxassetsgross": 100887000,
    "deferredtaxliabilitiesrightofuseasset": 1265000,
    "deferredtaxassetsvaluationallowance": 99622000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.062000000000000006,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.004,
    "effectiveincometaxratereconciliationnondeductibleexpenseofficerscompensation": -0.011000000000000001,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.028999999999999998,
    "effectiveincometaxratereconciliationuncertaintaxposition": -0.004,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.017,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.267,
    "effectiveincometaxratereconciliationtaxcreditsother": 0.002,
    "contraresearchanddevelopmentexpense": 1300000,
    "contraexpenseremainingamountincludedinaccruedexpenses": 2800000,
    "contraexpenseincludedinresearchanddevelopmentexpense": 3800000,
    "lesseeoperatingleaseoptiontoextend": "The lease may be extended for one five-year period at the then current market rate with annual escalations;",
    "operatingleasecost": 1900000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1987000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 2185000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 2251000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 522000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6945000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 906000,
    "operatingleaseliability": 6039000,
    "operatingleaseweightedaverageremainingleaseterm1": 3.25,
    "operatingleaseweightedaveragediscountratepercent": 0.084,
    "saleofstockpercentageofownershipaftertransaction": 0.046
  },
  {
    "date": "2020-12-30",
    "symbol": "ARCT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2020-12-31",
    "documentfiscalyearfocus": 2020,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ARCT",
    "entityregistrantname": "ARCTURUS THERAPEUTICS HOLDINGS INC.",
    "entitycentralindexkey": 1768224,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Large Accelerated Filer",
    "entitysmallbusiness": "false",
    "entityemerginggrowthcompany": "false",
    "icfrauditorattestationflag": "true",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "Yes",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38942",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "32-0595345",
    "entityaddressaddressline1": "10628 Science Center Drive",
    "entityaddressaddressline2": "Suite 250",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "900-2660",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "cashandcashequivalentsatcarryingvalue": 462895000,
    "accountsreceivablenetcurrent": 2125000,
    "prepaidexpensesandotherreceivables": 2769000,
    "assetscurrent": 467789000,
    "propertyplantandequipmentnet": 3378000,
    "operatingleaserightofuseasset": 5182000,
    "restrictedcashnoncurrent": 107000,
    "assets": 476456000,
    "accountspayablecurrent": 10774000,
    "accruedliabilitiescurrent": 20639000,
    "deferredrevenuecurrent": 18108000,
    "liabilitiescurrent": 49521000,
    "deferredrevenuenoncurrent": 12512000,
    "longtermdebtnoncurrent": 13845000,
    "operatingleaseliabilitynoncurrent": 4025000,
    "liabilities": 79903000,
    "commonstockvalue": 26000,
    "additionalpaidincapital": 540343000,
    "retainedearningsaccumulateddeficit": -143816000,
    "stockholdersequity": 396553000,
    "liabilitiesandstockholdersequity": 476456000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 60000000,
    "commonstocksharesissued": 26192000,
    "commonstocksharesoutstanding": 26192000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 9539000,
    "researchanddevelopmentexpense": 57846000,
    "generalandadministrativeexpense": 23217000,
    "operatingexpenses": 81063000,
    "operatingincomeloss": -71524000,
    "incomelossfromequitymethodinvestments": -263000,
    "othernonoperatingincomeexpense": -361000,
    "netincomeloss": -72148000,
    "earningspersharebasicanddiluted": -3.55,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 20305000,
    "comprehensiveincomenetoftax": -72148000,
    "sharesoutstanding": 26192000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 6764000,
    "stockissuedduringperiodvalueoptionexercised": 1000,
    "stockissuedduringperiodsharesoptionexercised": 600000,
    "stockissuedduringperiodvaluenewissues": 10000,
    "stockissuedduringperiodsharesnewissues": 10059000,
    "stockissuedduringperiodvaluestockoptionsexercised": 2726000,
    "stockissuedduringperiodsharesstockoptionsexercised": 395000,
    "depreciationandamortization": 882000,
    "sharebasedcompensation": 6764000,
    "lossfromequitymethodinvestments": 263000,
    "othernoncashinterestexpense": 162000,
    "increasedecreaseinaccountsreceivable": -54000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 2011000,
    "increasedecreaseinaccountspayable": 4812000,
    "increasedecreaseinaccruedliabilities": 11320000,
    "increasedecreaseincontractwithcustomerliability": 7041000,
    "netcashprovidedbyusedinoperatingactivities": -42861000,
    "paymentstoacquirepropertyplantandequipment": 1742000,
    "netcashprovidedbyusedininvestingactivities": -1742000,
    "proceedsfromstockoptionsexercised": 2726000,
    "proceedsfromexerciseofstockoptionandissuanceofcommonstockandoptionnetofissuancecosts": 9600000,
    "proceedsfromissuanceofcommonstock": 423819000,
    "netcashprovidedbyusedinfinancingactivities": 436145000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 391542000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 463002000,
    "interestpaidnet": 751000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 1360000,
    "capitalexpendituresincurredbutnotyetpaid": 169000,
    "numberofoperatingsegments": 1,
    "leaseexpirationyear": 2025,
    "concentrationrisknumberofcustomer": 1,
    "concentrationriskpercentage1": 1,
    "propertyplantandequipmentusefullife": "P3Y",
    "changeinaccountingprincipleaccountingstandardsupdateadopted": "true",
    "changeinaccountingprincipleaccountingstandardsupdateadoptiondate": "2019-03-31",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "contractwithcustomerassetnet": 2125000,
    "contractwithcustomerassetadditionsforrevenuerecognized": 4030000,
    "contractwithcustomerassetdeductionsforcashcollections": -4084000,
    "contractwithcustomerliability": 30620000,
    "contractwithcustomerliabilityadditionsforadvancedbillings": 16579000,
    "contractwithcustomerliabilityrevenuerecognized": -9538000,
    "upfrontpaymentreceived": 27900000,
    "revenuerecognitionpotentialmilestonerevenuerecognized": 138000000,
    "optionexerciserevenuerangepertarget": 1000000,
    "royaltypaymenttermdescription": "Ultragenyx will pay royalties as a single-digit percentage of net sales on a product-by-product and country-by-country basis during the applicable royalty term.",
    "revenuepracticalexpedientremainingperformanceobligationdescription": "The Company recognizes the reimbursement of labor and expenses as costs are incurred and none of the development and commercialization milestones were included in the transaction price, as all milestone amounts were fully constrained.",
    "contractwithcustomerassetcumulativecatchupadjustmenttorevenuechangeinestimateoftransactionprice": 1100000,
    "revenuerecognitionreservetargetexclusivityperiod": "P4Y",
    "developmentandoptionagreementdate": "2018-01",
    "expirationofintialterm": "P8Y",
    "optiontoextendinitialtermonanannualbasis": "P3Y",
    "upfrontfeereceived": 5000000,
    "collaborationagreementcontractualterm": "P31M",
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuemodificationofcontract": 400000,
    "percentageofcashpaymentsreceived": 0.1,
    "percentageofconsiderationreceived": 0.05,
    "sublicenserevenuerecognition": 300000,
    "revenuerelatedtoamortizationofupfrontpayment": 1000000,
    "numberofreservedvaccinedoses": 500000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "P21M",
    "employeerelatedliabilitiescurrent": 2097000,
    "accruedcysticfibrosisfoundationliability": 6585000,
    "accruedsingaporeeconomicdevelopmentboardliability": 1761000,
    "operatingleaseliabilitycurrent": 1630000,
    "operatingleaseliabilitycurrentstatementoffinancialpositionextensiblelist": "us-gaap:AccruedLiabilitiesCurrent",
    "longtermdebtcurrent": 1250000,
    "clinicalaccrualscurrent": 4067000,
    "otheraccruedresearchanddevelopmentexpenses": 3249000,
    "propertyplantandequipmentgross": 5539000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 3063000,
    "prepaymentfeepercentage": 0.02,
    "interestexpenselongtermdebt": 900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinnexttwelvemonths": 1250000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 7500000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 6550000,
    "longtermdebt": 15300000,
    "sharesissuedpricepershareofferingone": 17,
    "sharesissuedpricepershareofferingtwo": 53,
    "sharesissuedpricepershareofferingthree": 110,
    "proceedsfromissuanceofcommonstockgross": 452100000,
    "paymentsofstockissuancecosts": 28300000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 1157175,
    "commonstockcapitalsharesreservedforfutureissuance": 1257159,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumdiscountedpurchaseprice": 0.85,
    "allocatedsharebasedcompensationexpense": 100000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardmaximumdiscountedamount": 25000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 89800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P3Y2M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 4200000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P6Y14D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.724,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0074,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 42.33,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 3324713,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 2175184,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 104886,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 718301,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 3324713,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 46.03,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 66.91,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 6.82,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 21.37,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 10.11,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 46.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P9Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y11M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P9Y7D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 59449000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 23975000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 59449000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -72148000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -72148000,
    "maximumpercentageoflikelihoodofuncertaintaxpositionrecognizedtobesustained": 0.5,
    "unrecognizedtaxbenefits": 1500000,
    "operatinglosscarryforwards": 125800000,
    "taxcreditcarryforwardamount": 2300000,
    "taxcreditcarryforwardexpirationyear": 2033,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipminimumpercentage": 0.5,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipperiod": "P3Y",
    "unrecognizedtaxbenefitsincreasesresultingfrompriorperiodtaxpositions": 300000,
    "unrecognizedtaxbenefitsincreasesresultingfromcurrentperiodtaxpositions": 800000,
    "deferredtaxassetsoperatinglosscarryforwards": 33896000,
    "deferredtaxassetstaxcreditcarryforwards": 6278000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 535000,
    "deferredtaxassetsdeferredincome": 3230000,
    "deferredtaxassetsleaseliability": 1274000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 1338000,
    "deferredtaxassetsgross": 46551000,
    "deferredtaxliabilitiespropertyplantandequipmentandintangibleassets": 69000,
    "deferredtaxliabilitiesrightofuseasset": 1168000,
    "deferredtaxassetsvaluationallowance": 45314000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.068,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": 0.055,
    "effectiveincometaxratereconciliationnondeductibleexpenseresearchanddevelopment": 0.087,
    "effectiveincometaxratereconciliationuncertaintaxposition": -0.015,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.015,
    "effectiveincometaxratereconciliationrepatriationofforeignearnings": 0.285,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.674,
    "effectiveincometaxratereconciliationtaxcreditsother": -0.001,
    "contraresearchanddevelopmentexpense": 8700000,
    "contraexpenseremainingamountincludedinaccruedexpenses": 1300000,
    "recognizedcontraexpense": 3100000,
    "accruedliabilitiesfairvaluedisclosure": 500000,
    "contraexpenseincludedinresearchanddevelopmentexpense": 3400000,
    "operatingleasecost": 1900000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 2033000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1470000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1390000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1432000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 314000,
    "lesseeoperatingleaseliabilitypaymentsdue": 6639000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 984000,
    "operatingleaseliability": 5655000,
    "operatingleaseweightedaverageremainingleaseterm1": "P3Y10M13D",
    "operatingleaseweightedaveragediscountratepercent": 0.084,
    "saleofstockpercentageofownershipaftertransaction": 0.084
  },
  {
    "date": "2019-12-30",
    "symbol": "ARCT",
    "period": "FY",
    "documenttype": "10-K",
    "amendmentflag": "false",
    "documentperiodenddate": "2019-12-31",
    "documentfiscalyearfocus": 2019,
    "documentfiscalperiodfocus": "FY",
    "tradingsymbol": "ARCT",
    "entityregistrantname": "ARCTURUS THERAPEUTICS HOLDINGS INC.",
    "entitycentralindexkey": 1768224,
    "currentfiscalyearenddate": "--12-31",
    "entitycurrentreportingstatus": "Yes",
    "entityfilercategory": "Accelerated Filer",
    "entitysmallbusiness": "true",
    "entityemerginggrowthcompany": "false",
    "entityshellcompany": "false",
    "entitywellknownseasonedissuer": "No",
    "entityvoluntaryfilers": "No",
    "entityinteractivedatacurrent": "Yes",
    "security12btitle": "Common Stock, par value $0.001 per share",
    "securityexchangename": "NASDAQ",
    "entityfilenumber": "001-38942",
    "entityincorporationstatecountrycode": "DE",
    "entitytaxidentificationnumber": "32-0595345",
    "entityaddressaddressline1": "10628 Science Center Drive",
    "entityaddressaddressline2": "Suite 250",
    "entityaddresscityortown": "San Diego",
    "entityaddressstateorprovince": "CA",
    "entityaddresspostalzipcode": 92121,
    "cityareacode": 858,
    "localphonenumber": "900-2660",
    "documenttransitionreport": "false",
    "documentannualreport": "true",
    "cashandcashequivalentsatcarryingvalue": 71353000,
    "accountsreceivablenetcurrent": 2179000,
    "prepaidexpensesandotherreceivables": 758000,
    "assetscurrent": 74290000,
    "propertyplantandequipmentnet": 2349000,
    "operatingleaserightofuseasset": 5134000,
    "equitymethodinvestments": 263000,
    "restrictedcashnoncurrent": 107000,
    "assets": 82143000,
    "accountspayablecurrent": 5793000,
    "accruedliabilitiescurrent": 7134000,
    "deferredrevenuecurrent": 8397000,
    "liabilitiescurrent": 21324000,
    "deferredrevenuenoncurrent": 15182000,
    "longtermdebtnoncurrent": 14995000,
    "operatingleaseliabilitynoncurrent": 4850000,
    "liabilities": 56351000,
    "commonstockvalue": 15000,
    "additionalpaidincapital": 97445000,
    "retainedearningsaccumulateddeficit": -71668000,
    "stockholdersequity": -71668000,
    "liabilitiesandstockholdersequity": 82143000,
    "commonstockparorstatedvaluepershare": 0.001,
    "commonstocksharesauthorized": 30000000,
    "commonstocksharesissued": 15138000,
    "commonstocksharesoutstanding": 15138000,
    "revenuefromcontractwithcustomerexcludingassessedtax": 5900000,
    "researchanddevelopmentexpense": 33640000,
    "generalandadministrativeexpense": 12662000,
    "operatingexpenses": 46302000,
    "operatingincomeloss": -25513000,
    "incomelossfromequitymethodinvestments": -32000,
    "othernonoperatingincomeexpense": -446000,
    "netincomeloss": -25991000,
    "earningspersharebasicanddiluted": -2.15,
    "weightedaveragenumberofshareoutstandingbasicanddiluted": 12069000,
    "comprehensiveincomenetoftax": -25991000,
    "sharesoutstanding": 15138000,
    "adjustmentstoadditionalpaidincapitalsharebasedcompensationrequisiteserviceperiodrecognitionvalue": 1982000,
    "stockissuedduringperiodvalueredomiciliationshareexchange": 203000,
    "stockissuedduringperiodsharesredomiciliationshareexchange": -43000,
    "stockissuedduringperiodvaluerestrictedstockawardnetofforfeitures": 15545000,
    "stockissuedduringperiodsharesrestrictedstockawardnetofforfeitures": 2400000,
    "stockissuedduringperiodvaluenewissues": 21278000,
    "stockissuedduringperiodsharesnewissues": 1995000,
    "stockissuedduringperiodvaluestockoptionsexercised": 139000,
    "stockissuedduringperiodsharesstockoptionsexercised": 24290,
    "cumulativeeffectonretainedearningstax1": -803000,
    "depreciationandamortization": 684000,
    "sharebasedcompensation": 1982000,
    "lossfromequitymethodinvestments": 25000,
    "othernoncashincomeexpense": -873000,
    "increasedecreaseinaccountsreceivable": -2302000,
    "increasedecreaseinprepaiddeferredexpenseandotherassets": 120000,
    "increasedecreaseinaccountspayable": 3155000,
    "increasedecreaseinaccruedliabilities": 1675000,
    "increasedecreaseincontractwithcustomerliability": 800000,
    "netcashprovidedbyusedinoperatingactivities": -6445000,
    "paymentstoacquirepropertyplantandequipment": 818000,
    "netcashprovidedbyusedininvestingactivities": -818000,
    "proceedsfromissuanceoflongtermdebt": 4945000,
    "proceedsfromstockoptionsexercised": 139000,
    "proceedsfromissuanceofsharesunderincentiveandsharebasedcompensationplans": 15545000,
    "proceedsfromissuanceofcommonstock": 21278000,
    "netcashprovidedbyusedinfinancingactivities": 41907000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalentsperiodincreasedecreaseincludingexchangerateeffect": 34644000,
    "cashcashequivalentsrestrictedcashandrestrictedcashequivalents": 71460000,
    "interestpaidnet": 691000,
    "rightofuseassetobtainedinexchangeforoperatingleaseliability": 5868000,
    "capitalexpendituresincurredbutnotyetpaid": 240000,
    "stockholdersequitynotestocksplit": "one-for-one",
    "upfrontpaymentreceived": 27900000,
    "numberofoperatingsegments": 1,
    "leaseexpirationyear": 2025,
    "concentrationrisknumberofcustomer": 4,
    "concentrationriskpercentage1": 0.91,
    "equitymethodinvestmentownershippercentage": 0.19,
    "propertyplantandequipmentusefullife": "P5Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardexpirationperiod": "P10Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingperiod1": "P4Y",
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrightspercentage": 0.25,
    "sharebasedcompensationarrangementbysharebasedpaymentawardawardvestingrights": "Share-based compensation is recognized over the requisite service period of the individual awards using the straight-line attribution method, which generally equals the vesting period. Employees and officers’ share options have a ten-year life and generally vest 25% on the first anniversary of the grant and in 1/36th equal installments on each monthly anniversary thereafter, such that options are fully vested on the four-year anniversary of the date of grant.",
    "operatingleaseliability": 5677000,
    "contractwithcustomerassetnet": 2179000,
    "contractwithcustomerassetadditionsforrevenuerecognized": 17523000,
    "contractwithcustomerassetdeductionsforcashcollections": -19824000,
    "contractwithcustomerliability": 3200000,
    "contractwithcustomerliabilityadditionsforadvancedbillings": 30134000,
    "contractwithcustomerliabilitychangeintimeframeperformanceobligationsatisfiedrevenuerecognized": 803000,
    "contractwithcustomerliabilityrevenuerecognized": -21164000,
    "revenuerecognitionpotentialmilestonerevenuerecognized": 23000000,
    "optionexerciserevenuerangepertarget": 1500000,
    "royaltypaymenttermdescription": "CureVac will pay royalties as a percentage of net sales on a product-by-product and country-by-country basis during the applicable royalty term in the low single-digit range",
    "collaborationagreementtransactionprice": 5000000,
    "revenuepracticalexpedientremainingperformanceobligationdescription": "The Company recognizes the reimbursement of labor and expenses as costs are incurred and none of the development and commercialization milestones were included in the transaction price, as all milestone amounts were fully constrained.",
    "contractwithcustomerassetcumulativecatchupadjustmenttorevenuechangeinestimateoftransactionprice": 1100000,
    "revenuerecognitionreservetargetexclusivityperiod": "P4Y",
    "decreaseinaccumulateddeficit": 800000,
    "developmentandoptionagreementdate": "2018-01-31",
    "expirationofintialterm": "P8Y",
    "optiontoextendintialtermonanannualbasis": "P3Y",
    "collaborationagreementcontractualterm": "P46M",
    "contractwithcustomerliabilitycumulativecatchupadjustmenttorevenuemodificationofcontract": 400000,
    "percentageofcashpaymentsreceived": 0.2,
    "percentageofconsiderationreceived": 0.1,
    "upfrontfeereceived": 200000,
    "sublicenserevenuerecognition": 3300000,
    "revenuerelatedtoamortizationofupfrontpayment": 1300000,
    "laborreimbursementandoutofpocketrevenuerecognized": 400000,
    "revenueremainingperformanceobligationexpectedtimingofsatisfactionperiod1": "P33M",
    "employeerelatedliabilitiescurrent": 1608000,
    "accruedcysticfibrosisfoundationliability": 1949000,
    "operatingleaseliabilitycurrent": 827000,
    "otheraccruedresearchanddevelopmentexpenses": 2750000,
    "propertyplantandequipmentgross": 4530000,
    "accumulateddepreciationdepletionandamortizationpropertyplantandequipment": 2181000,
    "interestexpenselongtermdebt": 900000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyeartwo": 4000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearthree": 6000000,
    "longtermdebtmaturitiesrepaymentsofprincipalinyearfour": 5450000,
    "longtermdebt": 15450000,
    "percentageofcashfeeongrossproceedsfromoffering": 0.06,
    "saleofstockpercentageofownershipaftertransaction": 0.159,
    "unvestedrestrictedstockshares": 622667000,
    "antidilutivesecuritiesexcludedfromcomputationofearningspershareamount": 622667,
    "commonstockcapitalsharesreservedforfutureissuance": 927457,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognized": 5800000,
    "employeeservicesharebasedcompensationnonvestedawardstotalcompensationcostnotyetrecognizedperiodforrecognition1": "P2Y8M12D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedinperiodfairvalue1": 1900000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedterm1": "P5Y11M1D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsexpectedvolatilityrate": 0.739,
    "sharebasedcompensationarrangementbysharebasedpaymentawardfairvalueassumptionsriskfreeinterestrate": 0.0182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodweightedaveragegrantdatefairvalue": 6.39,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingnumber": 1649076,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsgrantsinperiodgross": 590115,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsforfeituresinperiod": 101182,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisablenumber": 581135,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisablenumber": 1649076,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageexerciseprice": 7.54,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsgrantsinperiodweightedaverageexerciseprice": 7.81,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsexercisesinperiodweightedaverageexerciseprice": 5.72,
    "sharebasedcompensationarrangementsbysharebasedpaymentawardoptionsforfeituresinperiodweightedaverageexerciseprice": 8.01,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageexerciseprice": 7.03,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageexerciseprice": 7.54,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingweightedaverageremainingcontractualterm2": "P8Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableweightedaverageremainingcontractualterm1": "P7Y8M4D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableweightedaverageremainingcontractualterm1": "P8Y7M2D",
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsoutstandingintrinsicvalue": 5498000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsexercisableintrinsicvalue1": 2236000,
    "sharebasedcompensationarrangementbysharebasedpaymentawardoptionsvestedandexpectedtovestexercisableaggregateintrinsicvalue": 5498000,
    "allocatedsharebasedcompensationexpense": 1982000,
    "incomelossfromcontinuingoperationsbeforeincometaxesdomestic": -25922000,
    "incomelossfromcontinuingoperationsbeforeincometaxesforeign": -69000,
    "incomelossfromcontinuingoperationsbeforeincometaxesminorityinterestandincomelossfromequitymethodinvestments": -25991000,
    "maximumpercentageoflikelihoodofuncertaintaxpositionrecognizedtobesustained": 0.5,
    "unrecognizedtaxbenefits": 200000,
    "opentaxyear": "2018 2019",
    "operatinglosscarryforwards": 89300000,
    "operatinglosscarryforwardsexpirationyear": 2034,
    "netoperatinglossexcludedfromdeferredtaxassets": 20500000,
    "taxcreditcarryforwardamount": 200000,
    "taxcreditcarryforwardexpirationyear": 2033,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipminimumpercentage": 0.5,
    "netoperatinglossandresearchanddevelopmentcreditcarryforwardslimitationsoncumulativechangeinownershipperiod": "P3Y",
    "deferredtaxassetsoperatinglosscarryforwards": 15078000,
    "deferredtaxassetstaxcreditcarryforwards": 28000,
    "deferredtaxassetstaxdeferredexpensereservesandaccrualsaccruedliabilities": 410000,
    "deferredtaxassetsdeferredincome": 1248000,
    "deferredtaxassetsleaseliability": 1466000,
    "deferredtaxassetstaxdeferredexpensecompensationandbenefitssharebasedcompensationcost": 339000,
    "deferredtaxassetsgross": 18569000,
    "deferredtaxliabilitiespropertyplantandequipmentandintangibleassets": 11000,
    "deferredtaxliabilitiesrightofuseasset": 1326000,
    "deferredtaxassetsvaluationallowance": 17232000,
    "effectiveincometaxratereconciliationatfederalstatutoryincometaxrate": 0.21,
    "effectiveincometaxratereconciliationstateandlocalincometaxes": 0.046,
    "effectiveincometaxratereconciliationforeignincometaxratedifferential": 0.003,
    "effectiveincometaxratereconciliationnondeductibleexpensesharebasedcompensationcost": -0.001,
    "effectiveincometaxratereconciliationchangeinenactedtaxrate": -0.001,
    "effectiveincometaxratereconciliationchangeindeferredtaxassetsvaluationallowance": -0.251,
    "effectiveincometaxratereconciliationtaxcreditsother": 0.001,
    "effectiveincometaxratereconciliationotheradjustments": -0.007,
    "contraexpenseincludedinresearchanddevelopmentexpense": 2000000,
    "contraexpenseremainingamountincludedinaccruedexpenses": 1900000,
    "operatingleasecost": 1200000,
    "lesseeoperatingleaseliabilitypaymentsduenexttwelvemonths": 1272000,
    "lesseeoperatingleaseliabilitypaymentsdueyeartwo": 1310000,
    "lesseeoperatingleaseliabilitypaymentsdueyearthree": 1349000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfour": 1390000,
    "lesseeoperatingleaseliabilitypaymentsdueyearfive": 1432000,
    "lesseeoperatingleaseliabilitypaymentsdueafteryearfive": 314000,
    "lesseeoperatingleaseliabilitypaymentsdue": 7067000,
    "lesseeoperatingleaseliabilityundiscountedexcessamount": 1390000,
    "operatingleaseweightedaverageremainingleaseterm1": "P5Y3M",
    "operatingleaseweightedaveragediscountratepercent": 0.084
  }
]